コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 d steering their interaction with follicular helper T cells.
2 ne profile favoring the generation of Type 1 helper T cells.
3 e network controlling the differentiation of helper T cells.
4 4, which allowed stable expression of Cd4 in helper T cells.
5 ter B cell support by PG-specific follicular helper T cells.
6 molecule CD28 is essential for activation of helper T cells.
7 d T cells, especially in the TH17 lineage of helper T cells.
8 he development of IL-17-producing pathogenic helper T cells.
9 per cell type 17 (T(H)17), and of follicular-helper T cells.
10 or typically expressed by the TH17 subset of helper T cells.
11 -)Sirpalpha(+) DCs induced the TH1 subset of helper T cells.
12 ity to differentiate into the TH17 subset of helper T cells.
13 chanism did not appear to be shared by mouse helper T cells.
14 in controlling the proallergic generation of helper T cells.
15 trong CD4 cytokine response involving type 1 helper T cells.
16 ferentiation into the TH2 and TH9 subsets of helper T cells.
17 phabeta(+) cytotoxic T lymphocytes or CD4(+) helper T cells.
18 ediated functional differentiation of CD4(+) helper T cells.
19 ewildering number of fates seem possible for helper T cells.
20 tion ex vivo by LN CD4(+)CXCR5(+) follicular helper T cells.
21 with the T(H)1, T(H)17 and T(H)22 subsets of helper T cells.
22 iated into pro-inflammatory T(H)1 and T(H)17 helper T cells.
23 1(+) (V6, P = .003; V8, P = .002) follicular helper T cells.
24 preciated metabolic control of plasticity in helper T cells.
25 ernalization and presentation of antigens to helper T cells.
26 efined here as synaptic ectosomes (SE), from helper T cells.
27 uggesting a large pool of S. aureus-reactive helper T-cells.
28 tokine produced by regulatory T-cells and by helper T-cells.
29 ncreases proliferation of cytotoxic, but not helper, T cells.
30 autoimmune diseases through differentiating helper T cell 1 (TH1) and maintaining TH17 responses.
31 F-alpha ratio and suppressed proinflammatory helper T cell 1 (Th1) cytokine expression by autologous
32 wn-regulated pathogenic pro-inflammatory and helper T cell 1 (Th1) responses and up-regulated benefic
33 IV) disease progression is associated with a helper T cell 1 (Th1) to helper T cell 2 (Th2) cytokine
34 rmine whether blockade of the interleukin 23-helper T cell 17 (IL-23-TH17) pathway with ustekinumab r
36 n particular, nicotine is found to promote a helper T cell 2 adaptive immunologic response within T c
37 FIV employs a distinct strategy to target helper T cells; a high affinity interaction with CD134 (
39 of their antigen receptor (TCR) by B cells, helper T cells act on B cells via CD40 ligand and secret
41 tipeptide vaccine (6MHP), designed to induce helper T cells against melanocytic and cancer-testis ant
42 rough liver-resident immunoregulatory CD4(+) helper T cells, alternatively activated macrophages, and
44 ecular interactions at the interface between helper T cells and antigen-presenting B cells govern the
45 as T(H)2, T(H)9, T(H)17, T(H)22, follicular helper T cells and CD28(null) T cells, as well as other
47 ir differentiation into the T(H)17 subset of helper T cells and colitogenic potential, in a manner de
49 hyperactive response of the T(H)17 subset of helper T cells and developed spontaneous IL-22-dependent
50 found a significant reduction in follicular helper T cells and germinal center B cells in these mice
51 nifestations and GATA2 deficiency, CD4+ CD3+ helper T cells and naive CD3+ CD4+ CD62L+ CD45RA+ helper
52 ed genes, increased the number of follicular helper T cells and plasmablasts in the spleen, and led t
54 ffector cells of the TH1 and TH17 subsets of helper T cells and the development of experimental autoi
55 is essential for the formation of follicular helper T cells and thus GCs, although whether IRF4 plays
56 ene expression specific to the TH2 subset of helper T cells and was important for the migration of TH
57 ting immune activation was assessed based on helper T-cell and regulatory T-cell activation in mice.
59 mediated by CD4(+)CXCR5(+)PD-1(+) follicular helper T cells, and can suppress inflammation in autoimm
60 renal allograft rejection induced by memory helper T cells, and CD8 T cell depletion at the time of
62 regulatory T cells (Treg), exhausted CD4(+) helper T cells, and myeloid-derived suppressor cells (MD
63 acilitated antigen-specific interaction with helper T cells, and promoted antibody affinity maturatio
64 he generation of antigen-specific follicular helper T cells, antigen-specific GC B cells, and high-af
68 TH17 cells (interleukin-17 (IL-17)-producing helper T cells) are highly proinflammatory cells that ar
69 row-infiltrating OX40+ cytotoxic T cells and helper T cells, as well as decreased ICOS+ and 4-1BB+ na
70 unctional antibody responses, via follicular helper T cells, as well as on the roles of CD4(+) T cell
71 ity complex (MHC) class II-restricted CD4(+) helper T cells but are also a common feature of MHC clas
72 class II complexes and defective priming of helper T cells but not of cytotoxic T lymphocyte (CTL) r
73 bility (MHC) class II complexes to stimulate helper T cells, but the genetic and regulatory basis for
76 ded double-negative, but depleted follicular helper, T-cell compartments and impaired Fas-dependent a
77 Furthermore, we find an association between helper T cell content in thyroid tissue and a COMMD3/DNA
79 ggerated airway eosinophilia, release type 2 helper T cell cytokines and exhibit airway hyper-respons
80 findings demonstrate that individual type 17 helper T-cell cytokines can have proinflammatory or anti
85 fibroblasts resulted in impaired follicular helper T cell differentiation and, consequently, in redu
86 ondary complications and a skewed follicular helper T-cell differentiation in defined monogenic immun
88 iRNA down-regulation promotes acquisition of helper T cell effector functions by relaxing the repress
89 ller cells (consisting of cytotoxic T cells, helper T cells, effector B cells, and natural killer cel
90 us, targeted TGF-beta signalling blockade in helper T cells elicits an effective tissue-level cancer
91 ht zone phenotype (site of Ag and follicular helper T cell encounter) express much higher levels of G
95 opment of innate-like T-cells and follicular helper T-cells, events that are known to require strong/
100 ter understanding of the mechanisms by which helper T cells function in the natural history of cholan
105 t to the profiling of circulating follicular helper T cells implicated in systemic lupus erythematosu
107 anti-fungal responses of the TH17 subset of helper T cells in controlling infection with Candida alb
108 ut the differentiation of pathogenic type 17 helper T cells in experimental autoimmune uveoretinitis
109 that endogenous cells of the TH17 subset of helper T cells in lymphoid organs of naive mice 'prefere
110 ion, mature B cells interact with follicular helper T cells in specialized structures called germinal
111 on of germinal center B cells and follicular helper T cells in the draining lymph node and Ag-specifi
114 for proper differentiation of types 1 and 2 helper T cells in vivo by restraining the expression and
115 r better showed greater maximum effector and helper T-cell increases, elevated antiviral and alloreac
120 that drive the differentiation of human CD4+ helper T cells into TFH cells remain largely undefined.
122 induced expression of FcgammaRIIIa on CD4(+) helper T-cells is an important finding since these recep
123 g cells) and the inflammatory TH17 subset of helper T cells leads to the development of autoimmune an
125 by key transcription factors, including the helper T cell master regulator ThPOK, which suppresses t
126 ell (Treg) subset that suppresses follicular helper T cell-mediated B cell responses in the germinal
127 essive interferon-gamma that directly limits helper T cell-mediated support of humoral immunity and d
130 ry T cells and lymph node-derived follicular helper T cells of patients with CVID compared with those
131 nd of coreceptors through which signals from helper T cells or pathogen-associated molecular patterns
132 e differentiation and function of follicular helper T cells or that of other helper T cell subsets.
133 on (P = 0.007) and CD25 expression on CD4(+) helper T cells (P = 0.0003) in the activated cord blood
137 pt predominantly type 1 helper or follicular helper T cell phenotypes in response to bacterial or vir
139 trates that CD28 persistence is required for helper T cell polarization in response to infection, des
141 )CXCR3(+) programmed death 1 (PD1)(hi)CD4(+) helper T cell population distinct from T(FH) cells and e
142 intenance and/or expansion of the follicular helper T cell population, although it was dispensable fo
143 nalysis we define an alpha4 nAChR expressing helper T-cell population (alpha4(+)CD3(+)CD4(+)) and sho
144 he resulting enlarged circulating follicular helper T-cell population from CVID+AIC subjects provided
146 sulted in the post-thymic termination of the helper T cell program and the functional differentiation
147 itory circuit that stabilizes the follicular helper T cell program at least in part through the contr
148 generation of an autoreactive TH17 subset of helper T cells, prominently associated with autoimmune d
149 T(H)2 and follicular helper T/ex-follicular helper T cells promotes asthma by inhibiting Treg cells.
150 elper T lymphocyte proportions and low naive helper T cell proportions are associated with those most
153 also discuss the role of mTOR in follicular helper T cells, regulatory T cells, and other T cell sub
154 rs experienced significant downregulation of helper T-cell-related (T(H)1, T(H)17, and T(H)22) mRNA e
157 the proteins contribute most strongly to the helper T cell response, highlight specific weaknesses of
158 mice developed an exaggerated type 1 and 17 helper T-cell response, characterized by natural killer
165 iew the current status of the flexibility of helper T-cell responses in relation to their genetic reg
166 mmunodeficiency viruses (FIV and HIV) target helper T cells selectively, and in doing so they induce
167 our findings suggest that the TH9 subset of helper T cells serves an important role in driving ulcer
169 what do terms like 'lineage commitment' and helper T-cell 'specification' mean in the early 21st cen
170 renal allograft rejection induced by memory helper T cells starting at day 4 after transplantation.
171 r T cells and naive CD3+ CD4+ CD62L+ CD45RA+ helper T cell subpopulation fractions were significantly
172 elper T cells (TFH cells) are the prototypic helper T cell subset specialized to enable B cells to fo
173 FOXP3-positive Treg cells are a critical helper T cell subset, and dysregulation of Treg generati
174 anti-tumor effects of a unique human CD4(+) helper T-cell subset that directly recognizes the cytopl
175 ve phenotypes that mirror those of polarized helper T cell subsets in their expression of core transc
178 e Notch family direct the differentiation of helper T cell subsets, but their influence on regulatory
182 ously defined 'master regulators' for CD4(+) helper T-cell subsets are also shared by ILC subsets.
183 t and functional divergence of the different helper T-cell subsets as well as in regulatory T cells.
187 an important regulator of other specialized helper T-cell subsets within germinal centers, pre-germi
188 ferentiation of naive CD4 T lymphocytes into helper T cells subtypes, including types 1, 2, and 17 he
189 lammatory diseases thought to be mediated by helper T-cell subtypes 1 and 2 (TH1 and TH2), respective
190 nteresting results include CSF enrichment of helper T cells (subtypes TH1 and TH17) and regulatory T
191 ntiated more readily into cytokine-producing helper T cells, suggesting that activation-induced miRNA
194 umulating evidence has shown that follicular helper T cell (T(FH)), a critical player in humoral immu
195 d T(reg) cell-mediated suppression of type 1 helper T cell (T(H)1 cell) responses and protected again
196 iota-dependent interleukin (IL)-17-producing helper T cell (T(H)17 cell) and immunoglobulin A respons
201 paralleled by the accumulation of follicular helper T cells (T(FH) cells) is linked to mutation of th
204 cells suppressed CD4 T cells and follicular helper T cells (T(FH)) in a perforin-dependent manner du
207 Given their functional relatedness to type 2 helper T cells (T(H)2 cells), we explored whether Gfi1 a
208 t the presence of pathogenic effector type 2 helper T cells (T(H)2) in asthmatic lungs and find evide
210 tches, such TH17 cells acquired a follicular helper T cell (TFH cell) phenotype and induced the devel
212 atory T cells (TFR cells) inhibit follicular helper T cell (TFH cell)-mediated antibody production.
214 le to identify a super-functional follicular helper T cell (Tfh)-like subpopulation in lupus-prone NZ
221 g the developmental mechanisms of follicular helper T cells (TFH cells) in humans is relevant to the
222 Aberrant population expansion of follicular helper T cells (TFH cells) occurs in patients with lupus
224 cy virus (HIV), which persists in follicular helper T cells (TFH cells), and Epstein-Barr virus (EBV)
228 ected germinal center (GC) CD4(+) follicular helper T cells (Tfh) after combination antiretroviral th
229 is is dependent on CD4(+)CXCR5(+) follicular helper T cells (TFH) and inhibited by CD4(+)CXCR5(+)Foxp
232 by the more recent definition of follicular helper T cells (Tfh) as the key T cell subset in B cell
233 In follicular lymphoma (FL), follicular helper T cells (TFH) have been depicted as one of the ma
236 ty and gene connectivity in human follicular helper T cells (TFH), a cell type required for anti-nucl
240 ssion also expanded the number of follicular helper T cells (TFHs) in a cell-intrinsic and Ag-specifi
241 the normal balance of pneumococcal-specific helper T cell (Th) 1/Th17 immunity to colonization, resu
242 n model on the mouse, and detect whether the helper T cells (Th) and regulatory T cells (Treg) could
243 -based vaccine formulation enhances systemic helper T cells TH1 and TH2 serum antibody and cytotoxic
244 Treg cell stability to repression of type 1 helper T cell (TH1 cell) and follicular helper T cell (T
245 between groups were observed for the type 1 helper T cell (TH1)-associated chemokines CXCL9 and CXCL
246 uding Slc2a1, Slc2a3, Pkm and Hk2, in type 1 helper T cells (TH1 cells) exposed to low concentrations
247 r the signaling pathways of type 1, 2 and 17 helper T cells (TH1, TH2 and TH17), JAK-STAT, interferon
248 naling, induces the expression of the type 1 helper T-cell (Th1) cytokine, interferon gamma, and supp
250 ne networks in the intestine associated with helper T cells' (Th1, Th2, and Th17) specific pathways.
251 negative Borrelia cultures, and the type 17 helper T cell (TH17)-associated cytokine interleukin 23
253 ntiation of interleukin 17 (IL-17)-producing helper T cells (TH17 cells) and follicular helper T cell
255 tion of interleukin (IL)-17-producing CD4(+) helper T cells (TH17 cells) has a pivotal role in autoim
256 mediated by interleukin 17 (IL-17)-producing helper T cells (TH17 cells) in the peripheral immune and
258 recently discovered interleukin-17 producing helper T cells (Th17), which are fundamental for anti-mi
259 al specimens reveals a predominantly type 17 helper T-cell (Th17)/Th1 signature, implicating this as
260 A-regulated pathways that control the type 2 helper T cell (TH2 cell) responses that drive pathogenic
264 ate lymphoid cells (ILC2s) and CD4(+) type 2 helper T cells (TH2 cells) are defined by their similar
265 p 2 innate lymphoid cells (ILC2s) and type 2 helper T cells (Th2 cells) are the primary source of int
266 interleukin-33 (IL-33), which induces type-2 helper T cells (Th2 cells) at the site of infection to p
269 with increased levels of eotaxins and type 2 helper T-cell (Th2) cytokines as disease progressed and
271 by dupilumab of these key drivers of type 2 helper T-cell (Th2)-mediated inflammation could help in
272 the differentiation of CD4(+) IL-9-producing helper T cells (TH9 cells) remain incompletely understoo
273 cells to differentiate into pro-inflammatory helper T cells that are prone to invade into tissue and
275 ility complex (MHC) class II-selected CD4(+) helper T cells that expressed CD8-lineage genes such as
276 dependent skin inflammation driven by CD4(+) helper T cells that produced the cytokines IL-17 and IL-
277 cells subtypes, including types 1, 2, and 17 helper T cells, that have more tailored immunologic resp
279 ate that they are not equivalent for CD4(+) 'helper' T cells, the principal orchestrators of adaptive
280 atory disease driven by the T(H)17 subset of helper T cells through molecular mechanisms that remain
281 ulates differentiation of the TH17 subset of helper T cells, thymic T cell development and lymph-node
282 The discovery of the specification of CD4(+) helper T cells to discrete effector 'lineages' represent
283 the expression of genes in the TH2 subset of helper T cells to enhancer occupancy by the BATF-IRF4 tr
286 L-5 circumsporozoite protein (CSP) ratios, a helper T cell type 2 cytokine, correlated with higher od
288 t mRNA level ratio, consistent with a type 2 helper T-cell-type inflammatory response, and subacute f
290 292, enhancing T-cell activation, in NSTEMI helper T cells versus SA and controls (each, p < 0.001),
291 ogate endogenous, Salmonella-specific CD4(+) helper T cells, we show that certain host microenvironme
294 er ICOS(+) populations, including peripheral helper T cells, were highly sensitive to costimulation b
295 ibodies require help from other lymphocytes (helper T cells) which recognize small peptides derived f
296 ncrease in numbers of circulating follicular helper T cells, which correlated with decreased regulato
297 F) gene (Batf(-/-)) lack TH17 and follicular helper T cells, which demonstrates that Batf is a transc
298 haracterized population of extrafollicular B helper T cells, which produced IL-10 and could play a pr
299 ls and CD4(+) Th cells, including follicular helper T cells, which resulted in high titers of anti-nu
300 103(+) DC subsets induced the TH17 subset of helper T cells, while CD103(-)Sirpalpha(+) DCs induced t
301 thogen containment to the differentiation of helper T cells, yet the cues that position cells in this